OPGEN INC stock forecast: up to 1.52 USD OPGN stock price prognosis


Forecast for Fri 28 Jul 2023 price 2.45

OPGEN INC stock price forecast for further price development up to 114.48% (time horizon: 1 day) and price target of 1.52 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) OPGEN INC share price prediction for 2023-07-28 with daily closed price projections

Key Facts

Symbol OPGN 

Currency USD

Category Services-Medical Laboratories

Forecast price change %

News sentiment (-0.43)

News <--> Close correlation for next day influence (-0.06)

Finance numbers

Revenue 4,425,716.0

Earnings per share -1.63

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

Commission file number 001-37367 ______________________ & OPGEN,& INC. ( Selected Financial Data & 54 Item 7. & New risks emerge from time to time. 3& & & & RISK FACTOR SUMMARY Investing in our securities involves a high degree of risk. Importantly, this summary does not address all of the risks that we face. Biofilm-forming pathogens can be detected by the Unyvero Platform. All fluids are handled within the sealed Application Cartridge. The IAI Application Cartridge The IAI Application Cartridge was launched in April 2017. A version of this product is currently pending FDA clearance. Our operations are located in the United States, Germany, and Austria. Each of these agreements can be extended by mutual agreement between the parties. Outside of the EU, OpGen currently plans to commercialize Unyvero through distributors. Under this agreement, Scholz guarantees that all such rights solely belong to Curetis. We also purchase our collection kits from sole-source suppliers. We are currently in the process of sunsetting our Argus intellectual property. & Class II devices are subject to General Controls as well as additional special controls. There are no regulatory safe harbors to the Maryland anti-kickback law. Among the safe harbors that may be relevant to us is the discount safe harbor. Throughout the COVID-19 pandemic, employee safety is of top priority. ldquo;AMR” means antimicrobial resistance. & We need to raise equity capital to support our business. If we cannot do so successfully, we will not be able to continue as a going concern. A number of special and complex rules apply in calculating this Section 382 limitation. We need to comply with the applicable laws and regulations regarding such other uses. If these collaborations are not successful, our business could be adversely affected. Competition for such employees is intense. We do not have redundant facilities for these products. Such process is complex, time consuming and expensive. We will monitor changes in government enforcement as we grow and expand our business. It is also more expensive for us to obtain director and officer liability insurance. 52& & & Item 1B. Unresolved Staff Comments None. Actual results could differ from those estimates. 333-202478, filed on April 23, 2015). & & & & & & & Accordingly, we express no such opinion. The Company analyzes each arrangement on a case-by-case basis. Options granted have a maximum term of 10 years. The Company will continue to monitor this matter going forward. The trade names/trademarks intangibles are valued using a relief-from-royalty method. The Company had no contract assets as of December 31, 2019. On June 11, 2018, the Company executed an Allonge to the MGHIF Note. In June 2018, another tranche of €3 million was drawn down. The Notes are dated April 22, 2020. Interest accrues on the Notes at the rate of 1.00% per annum. The entire proceeds were used under the Notes for such qualifying expenses. As of December 31, 2020, remaining availability under the ATM Agreement is $5.4 million. There can be no assurance that the NOL carryforward will ever be fully utilized. Ares Genetics received an option fee of approximately $550,000. M R/R/AV(B58IS*2IR#@CI0,]/B[U7U4XTN?Z58AZGZ56UC_ )! R\']:VL48H%J8G_ B6@\'_F&0_K2\'P?X/72H/U_P : MW,4N* U,+_A#?#O_ $"H/U_QI/\\ A#?#O_0*@_7_ ! \'O5^@0 MVJ4__\'PU7JHS_P#\'PU !_! M )[Q?]]BC[);_P#/"[email protected]?9+?\\ YX1?]\\"C0/=/*O\'!#:I$5(((EP1W_M7 M/VUNUU=101E0TKA 6. ,] Each pre-funded warrant

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1293818/000107997321000195/0001079973-21-000195.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 23.68/100
    • Not in ideal financial position.
    • Company revenue is not growing faster compared with the industry.

Bollinger Bollinger Bands for OPGEN INC can provide the information where the market is moving based on price information.

OPGEN INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns OPGEN INC.

On-Balance Volume information for OPGEN INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for OPGEN INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for OPGEN INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for OPGEN INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for OPGEN INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for OPGEN INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for OPGEN INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares

OPGEN INC on Nasdaq

OPGEN INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-06-28 1.52 2023-06-03 07:42
2023-06-19 1.24 2023-06-03 07:42
2023-06-20 1.29 2023-06-03 07:42
2023-06-21 1.33 2023-06-03 07:42
2023-06-06 0.87 2023-06-03 07:42
2023-06-07 0.93 2023-06-03 07:42
2023-06-08 0.96 2023-06-03 07:42
2023-06-09 1.01 2023-06-03 07:42
2023-06-12 1.04 2023-06-03 07:42
2023-06-13 1.10 2023-06-03 07:42
2023-06-14 1.13 2023-06-03 07:42
2023-06-15 1.16 2023-06-03 07:42
2023-06-16 1.20 2023-06-03 07:42
2023-06-22 1.37 2023-06-03 07:42
2023-06-23 1.40 2023-06-03 07:42
2023-06-26 1.45 2023-06-03 07:42
2023-06-27 1.49 2023-06-03 07:42
2023-06-29 1.56 2023-06-03 07:42
2023-06-30 1.61 2023-06-03 07:42
2023-07-03 1.67 2023-06-03 07:42
2023-07-05 1.75 2023-06-03 07:42
2023-07-04 1.71 2023-06-03 07:42
2023-07-06 1.79 2023-06-03 07:42
2023-07-07 1.84 2023-06-03 07:42
2023-07-10 1.88 2023-06-03 07:42
2023-07-11 1.92 2023-06-03 07:42
2023-07-12 1.96 2023-06-03 07:42
2023-07-13 2.00 2023-06-03 07:42
2023-07-14 2.04 2023-06-03 07:42
2023-07-17 2.08 2023-06-03 07:42
2023-07-18 2.13 2023-06-03 07:42
2023-07-19 2.17 2023-06-03 07:42
2023-07-20 2.21 2023-06-03 07:42
2023-07-21 2.25 2023-06-03 07:42
2023-07-24 2.29 2023-06-03 07:42
2023-07-25 2.33 2023-06-03 07:42
2023-07-27 2.41 2023-06-03 07:42
2023-07-26 2.37 2023-06-03 07:42
2023-07-28 2.45 2023-06-03 07:42

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.